Citation: | HUANG Zhengkai, YI Xiaomin, ZOU Junjie, GU Min, WANG Zengjun, JU Xiaobing. Retroperitoneal leiomyosarcoma involving the renal vein and inferior vena cava: a case report[J]. Journal of Clinical Medicine in Practice, 2021, 25(5): 83-86. DOI: 10.7619/jcmp.20201458 |
[1] |
RAJIAH P, SINHA R, CUEVAS C, et al. Imaging of uncommon retroperitoneal masses[J]. Radiographics: a review publication of the Radiological Society of North America, Inc, 2011, 31(4): 949-76. doi: 10.1148/rg.314095132
|
[2] |
COOLEY C L, JAGANNATHAN J P, KURRA V, et al. Imaging features and metastatic pattern of non-IVC retroperitoneal leiomyosarcomas: are they different from IVC leiomyosarcomas[J]. Journal of computer assisted tomography, 2014, 38(5): 687-92. doi: 10.1097/RCT.0000000000000097
|
[3] |
陈贵兵, 晏阳, 肖春红, 等. 原发性腹膜后平滑肌肉瘤局部复发和预后分析[J]. 中华外科杂志, 2014, 52(2): 105-108. doi: 10.3760/cma.j.issn.0529-5815.2014.02.006
|
[4] |
王关卉儿, 何廉波, 杨恺惟, 等. 腹膜后平滑肌肉瘤11例临床及病理分析[J]. 中华泌尿外科杂志, 2016, 37(12): 916-919. doi: 10.3760/cma.j.issn.1000-6702.2016.12.010
|
[5] |
杨文昶, 李睿东, 张鹏, 等. 原发性腹膜后平滑肌肉瘤31例诊治分析[J]. 腹部外科, 2019, 32(6): 435-438. doi: 10.3969/j.issn.1003-5591.2019.06.011
|
[6] |
OLIMPIADI Y, SONG S, HU J S, et al. Contemporary Management of Retroperitoneal Soft Tissue Sarcomas[J]. Current oncology reports, 2015, 17(8): 39. doi: 10.1007/s11912-015-0462-0
|
[7] |
SHINDO S, MATSUMOTO H, OGATA K, et al. Surgical treatment of retroperitoneal leiomyosarcoma invading the inferior vena cava: report of three cases[J]. Surgery today, 2002, 32(10): 929-933. doi: 10.1007/s005950200185
|
[8] |
房杰, 沈晨阳, 李清乐, 等. 腹膜后平滑肌肉瘤侵犯下腔静脉1例[J]. 中外健康文摘, 2010, 7(31): 113-113. https://www.cnki.com.cn/Article/CJFDTOTAL-RMJZ201602060.htm
|
[9] |
MARKO J, WOLFMAN D J. Retroperitoneal Leiomyosarcoma From the Radiologic Pathology Archives[J]. Radiographics: a review publication of the Radiological Society of North America, Inc, 2018, 38(5): 1403-1420. doi: 10.1148/rg.2018180006
|
[10] |
李晶英, 冯元春, 赵殿江. 腹膜后平滑肌肉瘤的临床、CT表现及病理分析[J]. 中国CT和MRI杂志, 2018, 16(2): 48-50. https://www.cnki.com.cn/Article/CJFDTOTAL-CTMR201802015.htm
|
[11] |
STORM F K, MAHVI D M. Diagnosis and management of retroperitoneal soft-tissue sarcoma[J]. Annals of surgery, 1991, 214(1): 2-10. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1358407
|
[12] |
LI B, LUO C H, ZHENG W. Risk factors for recurrence and survival in patients with primary retroperitoneal tumors[J]. Journal of BUON: official journal of the Balkan Union of Oncology, 2013, 18(3): 782-787. http://europepmc.org/abstract/med/24065499
|
[13] |
HARTMAN D S, HAYES W S, CHOYKE P L, et al. From the archives of the AFIP. Leiomyosarcoma of the retroperitoneum and inferior vena cava: radiologic-pathologic correlation[J]. Radiographics: a review publication of the Radiological Society of North America, Inc., 1992, 12(6): 1203-1220. doi: 10.1148/radiographics.12.6.1439022
|
[14] |
TEIXEIRA F J R, JR., DO COUTO NETTO S D, PERINA A L F, et al. Leiomyosarcoma of the inferior vena cava: Survival rate following radical resection[J]. Oncology letters, 2017, 14(4): 3909-3916. doi: 10.3892/ol.2017.6706
|
[15] |
LIU D, REN H L, LIU B, et al. Renal Function Preservation in Surgical Resection of Primary Inferior Vena Cava Leiomyosarcoma Involving the Renal Veins[J]. European journal of vascular and endovascular surgery: the official journal of the European Society for Vascular Surgery, 2018, 55(2): 229-239. doi: 10.1016/j.ejvs.2017.11.031
|
[16] |
PANTOJA J L, PATEL R P, BARIL D T, et al. Caval reconstruction with undersized ringed graft after resection of inferior vena cava leiomyosarcoma[J]. Ann Vasc Surg, 2020, 65: 25-32. doi: 10.1016/j.avsg.2019.11.007
|
[17] |
KALLURI A G, JAIN A K, RODRIGUEZ H E, et al. Polytetrafluoroethylene is a safe and effective interposition conduit for caval reconstruction after resection of primary leiomyosarcoma of the inferior vena cava[J]. Ann Vasc Surg, 2019, 58: 289-294. doi: 10.1016/j.avsg.2018.12.068
|
[18] |
PERVAIZ N, COLTERJOHN N, FARROKHYAR F, et al. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma[J]. Cancer, 2008, 113(3): 573-581. doi: 10.1002/cncr.23592
|
[19] |
LE CESNE A, OUALI M, LEAHY M G, et al. Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase Ⅲclinical trials[J]. Annals of oncology: official journal of the European Society for Medical Oncology, 2014, 25(12): 2425-2432. doi: 10.1093/annonc/mdu460
|
[20] |
李倩, 周宇红, 王妍, 等. 吉西他滨联合多西他赛一线治疗复发/转移性腹膜后平滑肌肉瘤[J]. 肿瘤, 2015, 35(1): 65-71. https://www.cnki.com.cn/Article/CJFDTOTAL-ZZLL201501011.htm
|
[21] |
VAN DER GRAAF W T, BLAY J Y, CHAWLA S P, et al. Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial[J]. Lancet, 2012, 379(9829): 1879-1886. doi: 10.1016/S0140-6736(12)60651-5
|